These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33875042)

  • 1. The Burden of Illness of Migraine in Canada: New Insights on Humanistic and Economic Cost.
    Amoozegar F; Khan Z; Oviedo-Ovando M; Sauriol S; Rochdi D
    Can J Neurol Sci; 2022 Mar; 49(2):249-262. PubMed ID: 33875042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States.
    Varnado OJ; Ye W; Mi X; Burge R; Hall J
    J Med Econ; 2023; 26(1):149-157. PubMed ID: 36601798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
    Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
    J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare utilization and costs among patients with chronic migraine, episodic migraine, and tension-type headache enrolled in commercial insurance plans.
    Shao Q; Rascati KL; Barner JC; Lawson KA; Sonawane KB; Rousseau JF
    Headache; 2022 Feb; 62(2):141-158. PubMed ID: 35156215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States.
    Dodick DW; Reed ML; Lee L; Balkaran BL; Umashankar K; Parikh M; Gandhi P; Buse DC
    Headache; 2024 Apr; 64(4):361-373. PubMed ID: 38523435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre.
    Negro A; Sciattella P; Rossi D; Guglielmetti M; Martelletti P; Mennini FS
    J Headache Pain; 2019 Dec; 20(1):120. PubMed ID: 31888448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
    Lublóy Á
    BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).
    Bloudek LM; Stokes M; Buse DC; Wilcox TK; Lipton RB; Goadsby PJ; Varon SF; Blumenfeld AM; Katsarava Z; Pascual J; Lanteri-Minet M; Cortelli P; Martelletti P
    J Headache Pain; 2012 Jul; 13(5):361-78. PubMed ID: 22644214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey.
    García-Azorín D; Moya-Alarcón C; Armada B; Sánchez Del Río M
    J Headache Pain; 2024 Mar; 25(1):38. PubMed ID: 38486155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway.
    Hansson-Hedblom A; Axelsson I; Jacobson L; Tedroff J; Borgström F
    J Headache Pain; 2020 Aug; 21(1):99. PubMed ID: 32787820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
    Kawata AK; Shah N; Poon JL; Shaffer S; Sapra S; Wilcox TK; Shah S; Tepper SJ; Dodick DW; Lipton RB
    Headache; 2021 Mar; 61(3):438-454. PubMed ID: 33594686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
    Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
    J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine.
    Hagan KK; Li W; Mostofsky E; Bertisch SM; Vgontzas A; Buettner C; Mittleman MA
    Headache; 2021 Mar; 61(3):493-499. PubMed ID: 33349935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study on the burden and impact of migraine on work productivity and quality of life in selected workplaces in the Philippines.
    Haw NJ; Cabaluna IT; Kaw GE; Cortez JF; Chua MP; Guce K
    J Headache Pain; 2020 Oct; 21(1):125. PubMed ID: 33109071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.